- Global Pharma News & Resources
22-Oct-2018 Shareholders Elect Directors at Meeting, Inc. (OTC Pink:HEWA), a Verified Internet Pharmacy Practice Site (VIPPS) accredited online pharmacy licensed and/or authorized to sell in all 50 states serving consumers who pay out of pocket for their prescriptions, today announced that its shareholders have elected nominees to new one-year terms on its Board of Directors, ratified proposals to modify an existing equity incentive plan, and appointed its auditing firm for the 2018 fiscal year.

Re-elected to the Board at the shareholders’ meeting on October 17, 2018, were Joseph Peters, CEO and President; Mark Scott, Chairman of the Board; Jack Britts, a business consultant and former CEO of Crown Laboratories and Merz Pharmaceuticals LLC; and Dr. Stephen Weiss, an independent outside director and president of the Sovereign Group of Companies, Inc., a real estate development and investment company.

Holders of the Company’s Series B Preferred shares separately elected Joe Heimbrock to hold the designated Series B Preferred seat on the Board. Heimbrock was a former commercial trucking industry executive who was first appointed to the Board in April 2016.

Shareholders also ratified two additional proposals. The first was the approval of an amendment to the 2014 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan and to make certain other changes. The second was to appoint Marcum LLP to serve as the Company’s independent registered public accounting firm for the year ended December 31, 2018.

About, Inc. (OTC Pink:HEWA) is a trusted VIPPS accredited online pharmacy based in Florence, Kentucky. The Company is focused on the out of pocket prescription market, which is expected to grow to over $50 billion in 2018. With a mission to provide affordable healthcare to every American by focusing on technology that is revolutionizing prescription delivery, has become the largest VIPPS accredited online pharmacy in the United States exclusively servicing the cash market. is licensed or authorized to ship prescription medication to all 50 states and only sells drugs that are FDA-approved and legal for sale in the United States. Visit online at

Forward-Looking Statements

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results may differ significantly from management's expectations. These forward-looking statements involve risks and uncertainties that include, among others, risks related to competition, management of growth, new products, services and technologies, potential fluctuations in operating results, international expansion, outcomes of legal proceedings and claims, fulfillment center optimization, seasonality, commercial agreements, acquisitions and strategic transactions, foreign exchange rates, system interruption, inventory, government regulation and taxation, and timing of cash flows. More information about factors that potentially could affect's financial results is included in's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent filings.

View source version on

Editor Details

Last Updated: 22-Oct-2018